| Entry |
|
| Name |
Azathioprine sodium (USP);
Imuran (TN)
|
| Product |
|
| Generic |
|
| Formula |
C9H7N7O2S. Na
|
| Exact mass |
300.028
|
| Mol weight |
300.2523
|
| Structure |

     |
| Activity |
|
| Remark |
|
| Interaction |
Genomic biomarker: TPMT [HSA: 7172]
 |
| Structure map |
| Immunosuppressive agents | | Antirheumatics - DMARDs and biological agents |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AX Other immunosuppressants
L04AX01 Azathioprine
D03033 Azathioprine sodium (USP)
USP drug classification [BR:br08302]
Immunological Agents
Immune Suppressants
Non-TNF Blockers
Azathioprine
D03033 Azathioprine sodium (USP)
 |
| Other DBs |
CAS: 55774-33-9 PubChem: DrugBank: LigandBox: |
| KCF data |
 ATOM 20
1 Z Na 22.1200 -19.1100
2 C8y C 18.8426 -17.5830
3 C8y C 17.6519 -18.2834
4 S2a S 18.8426 -16.1822
5 N5x N 20.0333 -18.2834
6 C8y C 17.6519 -19.6842
7 N4x N 16.3211 -17.7931
8 C8y C 17.6519 -15.4818
9 C8x C 20.0333 -19.6842
10 N5x N 16.3211 -20.1044
11 N5x N 18.8426 -20.3846
12 C8x C 15.4807 -18.9838
13 C8y C 17.6519 -14.0810
14 O3a O 20.1033 -14.0810 #-
15 N2b N 18.8426 -13.3806 #+
16 N5x N 16.3211 -13.6608
17 C8x C 15.4807 -14.7814
18 N4y N 16.3211 -15.9021
19 O3a O 18.8426 -11.9798
20 C1a C 15.1080 -16.6025
BOND 21
1 2 3 1
2 2 4 1
3 2 5 2
4 3 6 2
5 3 7 1
6 4 8 1
7 5 9 1
8 6 10 1
9 6 11 1
10 7 12 1
11 9 11 2
12 10 12 2
13 8 13 2
14 14 15 1
15 13 15 1
16 13 16 1
17 16 17 2
18 17 18 1
19 8 18 1
20 15 19 2
21 18 20 1
|